3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
12
Unknown
4
Terminated
2
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
2
Lymphoid
1
Head & Neck
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Papillomavirus Infections
1
Neoplasms
1
Neoplasm Metastasis
1
Endometrial Neoplasms
1
Interventions
Paclitaxel
80
Carboplatin
66
pembrolizumab
61
Bevacizumab
56
Cisplatin
48
Specimen Handling
29
Drug Therapy
26
Blood Specimen Collection
23
Cyclophosphamide
20
olaparib
19
Taxes
17
Magnetic Resonance Spectroscopy
16
Letrozole
16
Gemcitabine
16
Biopsy
16
liposomal doxorubicin
15
niraparib
14
fludarabine
14
Brachytherapy
14
Radiotherapy
13
abemaciclib
12
Topotecan
11
Nivolumab
11
Injections
11
Doxorubicin
11
lenvatinib
10
Fluorouracil
10
Surveys and Questionnaires
9
Standard of Care
9
Oxaliplatin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Imiquimod
×
Gynecologic
×
Clear all
NCT06686043
2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2
Recruiting
85 enrolled
NCT05405270
2023-09-11
PRedICT-TOPIC
Catharina Ziekenhuis Eindhoven
Recruiting
410 enrolled